{"id":"https://openalex.org/W3179973632","doi":"https://doi.org/10.1158/1538-7445.am2021-lb026","title":"Abstract LB026: Nanoscale, antigen-dependent, reversible IL-12 secretion by CAR T cells for cancer treatment","display_name":"Abstract LB026: Nanoscale, antigen-dependent, reversible IL-12 secretion by CAR T cells for cancer treatment","publication_year":2021,"publication_date":"2021-07-01","ids":{"openalex":"https://openalex.org/W3179973632","doi":"https://doi.org/10.1158/1538-7445.am2021-lb026","mag":"3179973632"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2021-lb026","doi":"https://doi.org/10.1158/1538-7445.am2021-lb026","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2021-lb026","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025711732","display_name":"Zhifen Yang","orcid":"https://orcid.org/0000-0003-1464-0140","observed_orcids":["https://orcid.org/0000-0003-1464-0140"]},"institutions":[{"id":"https://openalex.org/I4210146991","display_name":"Refuge Biotechnologies (United States)","ror":"https://ror.org/0520fx213","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhifen Yang","raw_affiliation_strings":["1Refuge Biotechnologies, Menlo Park, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Refuge Biotechnologies, Menlo Park, CA;","institution_ids":["https://openalex.org/I4210146991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018976466","display_name":"Maggie L. Bobbin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146991","display_name":"Refuge Biotechnologies (United States)","ror":"https://ror.org/0520fx213","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maggie Bobbin","raw_affiliation_strings":["1Refuge Biotechnologies, Menlo Park, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Refuge Biotechnologies, Menlo Park, CA;","institution_ids":["https://openalex.org/I4210146991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108125529","display_name":"Hana Choi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146991","display_name":"Refuge Biotechnologies (United States)","ror":"https://ror.org/0520fx213","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hana Choi","raw_affiliation_strings":["1Refuge Biotechnologies, Menlo Park, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Refuge Biotechnologies, Menlo Park, CA;","institution_ids":["https://openalex.org/I4210146991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008120312","display_name":"Ofir Stefanson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146991","display_name":"Refuge Biotechnologies (United States)","ror":"https://ror.org/0520fx213","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ofir Stefanson","raw_affiliation_strings":["1Refuge Biotechnologies, Menlo Park, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Refuge Biotechnologies, Menlo Park, CA;","institution_ids":["https://openalex.org/I4210146991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079661187","display_name":"Khristina Magallanes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146991","display_name":"Refuge Biotechnologies (United States)","ror":"https://ror.org/0520fx213","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khristina Magallanes","raw_affiliation_strings":["1Refuge Biotechnologies, Menlo Park, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Refuge Biotechnologies, Menlo Park, CA;","institution_ids":["https://openalex.org/I4210146991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112534408","display_name":"Jin Yang","orcid":"https://orcid.org/0009-0009-9078-127X","observed_orcids":["https://orcid.org/0009-0009-9078-127X"]},"institutions":[{"id":"https://openalex.org/I4210146991","display_name":"Refuge Biotechnologies (United States)","ror":"https://ror.org/0520fx213","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jin Yang","raw_affiliation_strings":["1Refuge Biotechnologies, Menlo Park, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Refuge Biotechnologies, Menlo Park, CA;","institution_ids":["https://openalex.org/I4210146991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100382530","display_name":"Bing Wang","orcid":"https://orcid.org/0000-0002-9038-9878","observed_orcids":["https://orcid.org/0000-0002-9038-9878"]},"institutions":[{"id":"https://openalex.org/I4210146991","display_name":"Refuge Biotechnologies (United States)","ror":"https://ror.org/0520fx213","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bing Wang","raw_affiliation_strings":["1Refuge Biotechnologies, Menlo Park, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Refuge Biotechnologies, Menlo Park, CA;","institution_ids":["https://openalex.org/I4210146991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050588157","display_name":"Alessandra Cesano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alessandra Cesano","raw_affiliation_strings":["2Essa Pharma, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Essa Pharma, South San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009068819","display_name":"Lei S. Qi","orcid":"https://orcid.org/0000-0002-3965-3223","observed_orcids":["https://orcid.org/0000-0002-3965-3223"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lei Stanley Qi","raw_affiliation_strings":["3Stanford University, Palo Alto, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Stanford University, Palo Alto, CA","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059941996","display_name":"Francesco Maria Marincola","orcid":"https://orcid.org/0000-0001-6423-391X","observed_orcids":["https://orcid.org/0000-0001-6423-391X"]},"institutions":[{"id":"https://openalex.org/I4210146991","display_name":"Refuge Biotechnologies (United States)","ror":"https://ror.org/0520fx213","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francesco M. Marincola","raw_affiliation_strings":["1Refuge Biotechnologies, Menlo Park, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Refuge Biotechnologies, Menlo Park, CA;","institution_ids":["https://openalex.org/I4210146991"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"81","issue":"13_Supplement","first_page":"LB026","last_page":"LB026"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10878","display_name":"CRISPR and Genetic Engineering","score":0.007300000172108412,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Bacterial Cancer Therapy","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/il-12","display_name":"IL-12","score":0.9309999942779541},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.9580000042915344},{"id":"https://openalex.org/keywords/crispr-activation","display_name":"CRISPR activation","score":0.875},{"id":"https://openalex.org/keywords/conditional-gene-expression","display_name":"conditional gene expression","score":0.7289999723434448},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.6579999923706055},{"id":"https://openalex.org/keywords/tev-protease","display_name":"TEV protease","score":0.6690000295639038},{"id":"https://openalex.org/keywords/dcas9","display_name":"dCas9","score":0.7689999938011169},{"id":"https://openalex.org/keywords/transcriptional-activator","display_name":"transcriptional activator","score":0.5690000057220459},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.6269999742507935},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.6060000061988831}],"concepts":[{"id":"https://openalex.org/C148125776","wikidata":"https://www.wikidata.org/wiki/Q1622348","display_name":"CD28","level":4,"score":0.6366968750953674},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5976198315620422},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4609653651714325},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.45827555656433105},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4494733512401581},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4362291693687439},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.42548519372940063},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.41429659724235535},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35198161005973816},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3518078327178955},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.25811538100242615},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.23349294066429138},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.19242388010025024},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.14619457721710205},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1436157524585724},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10572642087936401}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2021-lb026","doi":"https://doi.org/10.1158/1538-7445.am2021-lb026","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2021-lb026","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3106158817","https://openalex.org/W3211613799","https://openalex.org/W4322627031","https://openalex.org/W7133545016","https://openalex.org/W2046562334","https://openalex.org/W4362597405","https://openalex.org/W4404063842","https://openalex.org/W2109616567","https://openalex.org/W4308378124","https://openalex.org/W3082416279"],"abstract_inverted_index":{"Abstract":[0],"BACKGROUND":[1],"-":[2,55,185,269],"Interleukin(IL)-12":[3],"activates":[4],"T":[5,60,128,422],"cells":[6,198,222,256,292,333,423],"pivots":[7],"the":[8,65,114,158,169,181,252,260,264,328,344,347,355,382,431],"switch":[9],"that":[10,41,274,315],"turns":[11],"lingering":[12],"inflammation":[13,16],"into":[14],"acute":[15],"and":[17,77,95,107,161,163,209,302,360,373,443],"cancer":[18,197,425],"rejection.":[19],"However,":[20],"its":[21,72],"clinical":[22],"utilization":[23],"is":[24,57,380],"limited":[25],"by":[26,298,334,420],"severe":[27],"systemic":[28,361],"toxicity.":[29,362],"Here,":[30],"we":[31],"present":[32],"a":[33,58,82,101,139,224,318],"conditional,":[34],"antigen-dependent,":[35,416],"non-editing":[36],"CRISPR-activation":[37],"(CRISPRa)":[38],"circuit":[39,80],"(RB-2-12)":[40],"induces":[42],"minimally":[43],"effective":[44],"doses":[45,231],"of":[46,51,71,127,144,168,190,204,232,237,242,277,290,317,330,337,350,357,384,430],"IL-12":[47,66,182,191,265,324,352,418],"for":[48,117,125,154,424,434],"autocrine":[49,348],"activation":[50,126,283],"CAR-T":[52,221,291,332],"cells.":[53],"METHODS":[54],"RB-2-12":[56,172,186,238,258,385],"CAR":[59,145,282,421],"cell":[61,227],"engineered":[62],"to":[63,100,131,150,157,177,194,217,248,309,340],"express":[64],"heterodimer":[67],"via":[68,138],"conditional":[69],"transcription":[70],"two":[73,108],"endogenous":[74],"subunits":[75,267],"p35":[76],"p40.":[78],"The":[79],"includes":[81],"lentiviral":[83],"constructs":[84,122],"encoding":[85],"an":[86],"anti-HER2":[87],"(4D5)":[88],"single":[89,109],"chain":[90],"variable":[91],"fragment,":[92],"with":[93,223,251],"CD28":[94],"CD3\u03b6":[96],"co-stimulatory":[97],"domains":[98],"linked":[99],"tobacco":[102],"etch":[103],"virus":[104],"(TEV)":[105],"protease":[106],"guide":[110,261],"RNAs":[111,262],"(sgRNA)":[112],"targeting":[113,263],"promoter":[115],"region":[116],"IL-12A":[118],"orL-12B.":[119],"A":[120],"second":[121],"encodes":[123],"linker":[124,141],"cells,":[129],"complexed":[130],"nuclease-deactivated/dead":[132],"Cas9":[133],"(dCas9)-VP64-p65-Rta":[134],"transcriptional":[135],"activator":[136],"(VPR)":[137],"TEV-cleavable":[140],"(LdCV).":[142],"Activation":[143],"brings":[146],"CAR-TEV":[147],"in":[148,175,200,293,371,374,386],"proximity":[149],"LdCV":[151],"releasing":[152],"dCas9":[153],"nuclear":[155],"localization":[156],"regulatory":[159],"regions":[160],"conditionally":[162],"reversibly":[164],"induce":[165],"nanoscale":[166,351],"expression":[167,279],"p70":[170],"heterodimer.":[171],"was":[173],"compared":[174,247],"vitro":[176,372],"control":[178],"(cRB-2-12,":[179],"lacking":[180,259],"sgRNAs).":[183],"Results":[184],"induced":[187],"low":[188],"concentrations":[189],"upon":[192,280],"exposure":[193],"HER2+":[195],"FaDu":[196,226,245,389],"resulting":[199],"significantly":[201,239],"enhanced":[202,240],"production":[203,353],"interferon":[205],"(IFN)-\u03b3,":[206],"cytotoxic":[207],"activity":[208],"proliferation":[210],"(Figure":[211],"1a).":[212],"These":[213],"effects":[214,349],"were":[215],"comparable":[216],"co-culturing":[218],"conventional":[219,254],"HER2-specific":[220],"modified":[225],"line":[228],"expressing":[229],"high":[230],"IL-12.":[233],"In":[234],"vivo":[235,294,375,387],"administration":[236],"survival":[241],"mice":[243,249],"carrying":[244],"xenografts":[246,297],"treated":[250],"respective":[253],"CAR-t":[255],"or":[257],"gene":[266],"CONCLUSIONS":[268],"We":[270,313],"have":[271],"previously":[272],"shown":[273],"tandem":[275],"suppression":[276],"PD-1":[278],"HER-2":[281],"using":[284],"CRISPR":[285],"interference":[286],"enhances":[287],"anti-cancer":[288],"properties":[289],"against":[295,388],"HER2-FaDu":[296],"promoting":[299],"their":[300],"persistence":[301],"long-term":[303],"tumor":[304],"colonization":[305],"(companion":[306],"abstract":[307],"submitted":[308],"SITC":[310],"annual":[311],"meeting).":[312],"hypothesize":[314],"addition":[316],"Th1":[319],"polarizing":[320],"component":[321],"such":[322],"as":[323],"will":[325],"exponentially":[326],"increase":[327],"efficacy":[329],"reprogrammed":[331],"combining":[335],"enhancement":[336],"effector":[338],"functions":[339],"cellular":[341],"fitness.":[342],"At":[343],"same":[345],"time,":[346],"limit":[354],"risk":[356],"off-tumor":[358],"leakage":[359],"Such":[363],"cumulative":[364],"synthetic":[365],"biology":[366],"approaches":[367],"are":[368],"currently":[369],"investigated":[370],"model":[376],"systems.":[377],"Current":[378],"work":[379],"testing":[381],"effectiveness":[383],"xenografts.":[390],"Citation":[391],"Format:":[392],"Zhifen":[393],"Yang,":[394,404],"Maggie":[395],"Bobbin,":[396],"Hana":[397],"Choi,":[398],"Ofir":[399],"Stefanson,":[400],"Khristina":[401],"Magallanes,":[402],"Jin":[403],"Bing":[405],"Wang,":[406],"Alessandra":[407],"Cesano,":[408],"Lei":[409],"Stanley":[410],"Qi,":[411],"Francesco":[412],"M.":[413],"Marincola.":[414],"Nanoscale,":[415],"reversible":[417],"secretion":[419],"treatment":[426],"[abstract].":[427],"In:":[428],"Proceedings":[429],"American":[432],"Association":[433],"Cancer":[435,449],"Research":[436],"Annual":[437],"Meeting":[438],"2021;":[439],"2021":[440],"Apr":[441],"10-15":[442],"May":[444],"17-21.":[445],"Philadelphia":[446],"(PA):":[447],"AACR;":[448],"Res":[450],"2021;81(13_Suppl):Abstract":[451],"nr":[452],"LB026.":[453]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-07-19T00:00:00"}